Telavancin, a new lipoglycopeptide antimicrobial, in complicated skin and soft tissue infections

Overview of attention for article published in Infection and Drug Resistance, March 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 24 Mendeley

Summary Patents Dimensions citations

So far, Dimensions has found 7 publications that cite this research output.

7

The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.

Synergistic Antibacterial Activity with Conventional Antibiotics and Mechanism of Action of Shikonin against Methicillin-Resistant Staphylococcus aureus

Article in International Journal of Molecular Sciences (July 2022)

Skin and Soft-Tissue Infections: A Critical Review and the Role of Telavancin in Their Treatment

Article in Clinical Infectious Diseases (August 2015)

Potency and penetration of telavancin in staphylococcal biofilms

Article in International Journal of Antimicrobial Agents (July 2015)